ArticleDiabetologia2018

Oral histone deacetylase inhibitor synergises with T cell targeted immunotherapy to preserve beta cell metabolic function and induce stable remission of new-onset autoimmune diabetes in NOD mice.

Alix Besançon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.